Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27847841 | 0.82 | ALDH1A1 (0.55) | MCL1ALDH1A1CYP1A2HPGDHSD17B10 | |
| SCHEMBL8320177 | 0.80 | MCL1 (0.53) | MCL1ALDH1A1CYP1A2HPGDHSD17B10 | |
| Cyanate SCHEMBL22436247 | 0.80 | ALDH1A1 (0.52) | MCL1ALDH1A1CYP1A2HPGDHSD17B10 | |
| Water SCHEMBL30762258 | 0.76 | ALDH1A1 (0.67) | MCL1ALDH1A1CYP1A2HPGDHSD17B10 | |
| SCHEMBL28137055 | 0.76 | MAPT (0.35) | MCL1ALDH1A1THRBTSHRKDM4E | |
| Water SCHEMBL4564698 | 0.76 | ALDH1A1 (0.67) | MCL1ALDH1A1CYP1A2HPGDHSD17B10 | |
| SCHEMBL28891826 | 0.75 | ALDH1A1 (0.52) | MCL1ALDH1A1CYP1A2HPGDHSD17B10 | |
| SCHEMBL8054171 | 0.74 | MEN1 (0.34) | MCL1ALDH1A1THRBTSHRKDM4E | |
| SCHEMBL1051092 | 0.74 | MEN1 (0.34) | MCL1ALDH1A1THRBTSHRKDM4E | |
| SCHEMBL1501109 | 0.74 | MEN1 (0.34) | MCL1ALDH1A1THRBTSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114004825-A | Water surface oil spill detection algorithm based on infrared sequence image | 南通智能感知研究院 | 2022-02-01 | — | — | CN | claimed |
| EP-4706525-A2 | ELECTROMECHANICAL PILL DEVICE WITH LOCALIZATION CAPABILITIES | BT Bidco, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260033738-A1 | Electromechanical Pill Device with Localization Capabilities | BT BIDCO INC (US) | 2026-02-05 | — | — | US | disclosed |
| EP-3799776-B1 | ELECTROMECHANICAL PILL DEVICE WITH LOCALIZATION CAPABILITIES | BT BIDCO INC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12446794-B2 | Electromechanical pill device with localization capabilities | BT BIDCO, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| CN-119030552-A | Communication method, device, storage medium and chip | 北京小米移动软件有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-20240358273-A1 | Electromechanical Pill Device with Localization Capabilities | GLAS USA LLC | 2024-10-31 | — | — | US | disclosed |
| EP-3512938-B1 | RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG | UNIV ALBERTA (CA) | 2024-08-28 | — | — | EP | disclosed |
| US-20240273727-A1 | GENERATING IMAGE-BASED BIOMARKERS FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIAS | Siemens Healthineers Ag (DE) | 2024-08-15 | — | — | US | disclosed |
| EP-4414998-A1 | GENERATING IMAGE-BASED BIOMARKERS FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIAS | Siemens Healthineers AG (DE) | 2024-08-14 | — | — | EP | disclosed |
| US-12053271-B2 | Electromechanical pill device with localization capabilities | BIORA THERAPEUTICS, INC. (US) | 2024-08-06 | — | — | US | disclosed |
| CN-117977714-A | Power control method, device, storage medium and processor | 广东电网有限责任公司 | 2024-05-03 | — | — | CN | disclosed |
| US-20240066144-A1 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-02-29 | — | — | US | disclosed |
| US-20230235290-A1 | RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG | UNIV ALBERTA (CA) | 2023-07-27 | — | — | US | disclosed |
| US-11633502-B2 | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-04-25 | — | — | US | disclosed |
| US-11591570-B2 | Recombinant cardiomyocytes and cardiomyocyte cell lines expressing hERG | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2023-02-28 | — | — | US | disclosed |
| CN-114004825-A | Water surface oil spill detection algorithm based on infrared sequence image | 南通智能感知研究院 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230235290-A1 | RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG | TNNI3, MYLK2, TNNT2 | MCL1 982/4885ALDH1A1 3827/4885CYP1A2 3515/4885 |
| US-11633502-B2 | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use | BST2, LIPG, LDLR | MCL1 22/4885ALDH1A1 1934/4885CYP1A2 1187/4885 |
| US-20240066144-A1 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | BST2, LIPG, LDLR | MCL1 18/4885ALDH1A1 1920/4885CYP1A2 1322/4885 |
| US-11591570-B2 | Recombinant cardiomyocytes and cardiomyocyte cell lines expressing hERG | KCNJ2, KCNH2, KCNE1 | MCL1 1156/4885ALDH1A1 2059/4885CYP1A2 1328/4885 |
| US-20260033738-A1 | Electromechanical Pill Device with Localization Capabilities | MLNR, PIEZO1, GIPR | MCL1 4735/4885ALDH1A1 1073/4885CYP1A2 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.